Loading investment round...
Loading investment round...
Avant Genomics — Developing an automated platform for liquid biopsy sample preparation.
Avant Genomics has secured $3 million in its first funding round to accelerate the development of its automated liquid biopsy sample preparation platform, Avant Source™. This capital infusion will support further product development and commercialization efforts. The company aims to streamline the process of preparing samples for cancer detection and monitoring.
No investors disclosed.